MedPath

Global Blood Therapeutics, Inc.

Global Blood Therapeutics, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2011-02-01
Employees
457
Market Cap
-
Website
http://www.gbt.com

Clinical Trials

36

Active:23
Completed:4

Trial Phases

3 Phases

Phase 1:23
Phase 2:3
Phase 3:8

Drug Approvals

1

FDA:1

Drug Approvals

OXBRYTA

Approval Date
Dec 26, 2023
FDA

Clinical Trials

Distribution across different clinical trial phases (35 trials with phase data)• Click on a phase to view related trials

Phase 1
23 (65.7%)
Phase 3
8 (22.9%)
Phase 2
3 (8.6%)
phase_2_3
1 (2.9%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.